Craig Walker, MD, comments on a study by Estes and colleagues that reported on 19 patients presenting with acute limb ischemia who were treated with acoustic pulse therapy coupled with thrombolytic infusion.
These two videos accompany the article by Benjaout and colleagues on middle aortic syndrome.
Thomas Zeller, MD, reported on 5-year follow-up data for the use of a drug-coated balloon (DCB) below the knee in the IN.PACT DEEP trial.
Tim Yates, MD, discusses the pros and cons of antegrade or retrograde for CLI therapy.
Craig Walker, MD, comments on the treatment of a 90-year-old man with a chronic, non-healing venous leg ulcer. The patient had received more than 6 months of intensive, aggressive wound therapy with no improvement.
Richard Neville, MD, offers an update on on the goals and design of the BEST-CLI (Best Endovascular vs Best Surgical Therapy for Patients With Critical Limb Ischemia) trial, a multidisciplinary study.
Donna Pietraszek, MD, discusses the abstract she presented at AMP 2019, "Amputation Rates for Patients With Diabetic Foot Ulcers at the Community Level: An Income-Based Analysis"
Snehitha Vijaykumar, MD, describes the abstract she presented at AMP on chocolate balloon angioplasty as an adjunctive therapy in CLI patients. She talks about the methodology of her study, the results, and plans for future research.
Robert Beasley, MD, and Mahmood Razavi, MD, discuss the challenges of treating below-the-knee disease and how the MicroStent by Micromedical can help to improve outcomes. For more information on STAND or the MicroStent visit …